IL2 and metastatic melanoma: In the current study, we demonstrated that 99mTc-HYNIC-IL2 scintigraphy is a safe non-invasive clinical examination to assess the presence and changes in TIL in metastatic melanoma lesions in patients undergoing IO therapy with ipilimumab or pembrolizumab.